Predictors of Adherence to Orencia

Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis

NCT05782335 ·Status: RECRUITING

Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin

NCT03466814 ·Status: COMPLETED

Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL

NCT02600455 ·Status: COMPLETED

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

NCT00134693 ·Status: COMPLETED ·Phase: PHASE2

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

NCT00110903 ·Status: COMPLETED ·Phase: PHASE3

Korean Post-marketing Surveillance for Orencia®

NCT01583244 ·Status: COMPLETED

Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects

NCT00706797 ·Status: TERMINATED ·Phase: PHASE4

Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes

NCT00094341 ·Status: COMPLETED ·Phase: PHASE4

Long-term Experience With Abatacept SC in Routine Clinical Practice

NCT02090556 ·Status: COMPLETED

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

NCT02986139 ·Status: COMPLETED ·Phase: PHASE3

Observational Real-world Evaluation of Cost of Infections of Rheumatoid Arthritis (RA) Patients on Biologics

NCT01166620 ·Status: COMPLETED

Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis

NCT01717846 ·Status: WITHDRAWN ·Phase: PHASE4

Long Term Experience With Abatacept in Routine Clinical Practice

NCT02109666 ·Status: COMPLETED

Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis

NCT00989235 ·Status: COMPLETED ·Phase: PHASE3

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

NCT04343378 ·Status: COMPLETED

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

NCT01875991 ·Status: COMPLETED ·Phase: PHASE4

Enbrel Liquid Immunogenicity Protocol

NCT00249041 ·Status: COMPLETED ·Phase: PHASE3

Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice

NCT02202837 ·Status: COMPLETED

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

NCT01646385 ·Status: COMPLETED

Ancillary Study to Protocol 20060104

NCT00439894 ·Status: COMPLETED

Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

NCT00459706 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept

NCT01221636 ·Status: WITHDRAWN ·Phase: PHASE1

Good EULAR Response In Patients With Early Rheumatoid Arthritis

NCT01558089 ·Status: COMPLETED

The Study of Abatacept in Combination With Etanercept

NCT00162279 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, Massachusetts (MA) Facility of Bristol-Myers Squibb

NCT01439204 ·Status: COMPLETED ·Phase: PHASE1